Development of a continuous IL-7-dependent murine pre-B cell line PB-1 suitable for the biological characterisation and assay of human IL-7

Journal of Immunological Methods

Volumn 236, Issue 1-2, 2000, Pages 71-76

  Mire Sluis, Anthony R ^a   Healey, Lyn ^b   Griffiths, Steve ^b   Hockley, David ^a   Thorpe, Robin ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b Leukaemia Research Fund Centre   (United Kingdom)

Author keywords

Bioassay; Cytokine; IL 7; Interleukin 7

Indexed keywords

ACTIVIN A; ALPHA INTERFERON; CONSENSUS INTERFERON; CYTOKINE; CYTOKINE ANTIBODY; INHIBIN A; INTERLEUKIN 7; LEUKEMIA INHIBITORY FACTOR; NEUTRALIZING ANTIBODY; ONCOSTATIN M; RECOMBINANT ACTIVIN A; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT CYTOKINE; RECOMBINANT EPIDERMAL GROWTH FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INHIBIN A; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 5; RECOMBINANT INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 7; RECOMBINANT INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 9; RECOMBINANT LEUKEMIA INHIBITORY FACTOR; RECOMBINANT ONCOSTATIN M; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BIOASSAY; BONE MARROW CELL; CELL GROWTH; CELL LINE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FREEZING; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PLASMA; PRIORITY JOURNAL; SERUM; STORAGE;

ANIMALS; B-LYMPHOCYTES; BIOLOGICAL ASSAY; CELL DIVISION; CELL LINE; EVALUATION STUDIES; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-7; MICE; MICROSCOPY, ELECTRON; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

MURINAE;

EID: 0033965597     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00237-9     Document Type: Article

References (13)

1. Akashi K., Kondo M., Weissman I.L. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev. 165:1998;13.
2. Statistical Analysis of Results of Biological Assays and Tests. 1997;299.
3. Hockley D.J., Wood R.D., Jacobs J.P., Garrett A.J. Electron microscopy of human immunodeficiency virus. J. Gen. Virol. 69:1988;2455.
4. Ishihara K., Medina K., Hayashi S., Pietrangeli C., Namen A.E., Miyake K., Kincade P.W. Stromal-cell and cytokine-dependent lymphocyte clones which span the pre-B- to B-cell transition. Dev. Immunol. 1:1991;149.
5. Mire-Sluis A.R., Thorpe R. Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. J. Immunol. Methods. 211:1998;199.
6. Mire-Sluis A.R., Gaines Das R., Thorpe R. Immunoassays for detecting cytokines: what are they really measuring? J. Immunol. Methods. 186:1995;157.
7. Mire-Sluis A.R., Gerrard T., Das R.G., Padilla A., Thorpe R. Biological assays: their role in the development and quality control of recombinant biological medicinal products. Biologicals. 24:1996;351.
8. Namen A., Mire-Sluis A. Interleukin-7. Mire-Sluis A.R., Thorpe R. Cytokines. 1998;109 Academic Press, London.
9. Namen A., Schmierer A., March C., et al. B-cell precursor growth-promoting activity: purification and characterization of a growth factor active on lymphocyte precursors. J. Exp. Med. 167:1988;988.
10. Or R., Abdul Hai A., Ben Yehuda A. Reviewing the potential utility of interleukin-7 as a promoter of thymopoiesis and immune recovery. Cytokines Cell. Mol. Ther. 4:1998;287.
11. Park L.S., Friend D.J., Schmierer A.E., Dower S.K., Namen A.E. Murine interleukin-7 (IL-7) receptor: characterization on an IL-7-dependent cell line. J. Exp. Med. 171:1990;1073.
12. Pietrangeli C.E., Hayashi S., Kincade P.W. Stromal cell lines which support lymphocyte growth: characterization, sensitivity to radiation and responsiveness to growth factors. Eur. J. Immunol. 18:1988;863.
13. Sica D., Rayman P., Stanley J., et al. Interleukin-7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int. J. Cancer. 53:1993;941.